Neurology Minute

Latest Episodes:

Spinal Muscular Atrophy Update in Best Practices - Part 3 Sep 09, 2024

Show notes

In the third episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the critical objective of advancing the quality of life for individuals with SMA in the coming years.

Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310

Specialist Physiotherapy for Functional Motor Disorder Sep 06, 2024

Show notes

Dr. David Perez and Dr. Glenn Nielsen discuss the effectiveness of physiotherapy in treating functional motor disorder and to determine the best approach for physiotherapy treatment.

Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00135-2/fulltext

Spinal Muscular Atrophy Update in Best Practices - Part 2 Sep 05, 2024

Show notes

In the second episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the currently available treatments for spinal muscular atrophy.

Show reference:

https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310

Spinal Muscular Atrophy Update in Best Practice - Part 1 Sep 04, 2024

Show notes

In the first episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the most common types of spinal muscular atrophy.

Show reference:

https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310

Blood Biomarkers to Detect Alzheimer Disease - Part 2 Sep 03, 2024

Show notes

In part two of this series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss how this new blood test can enhance the accuracy of diagnosing Alzheimer's disease in patients with cognitive symptoms.

Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669

Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 2 Sep 02, 2024

Show notes

In the second part of this two-part series, Dr. Jeff Ratliff and Dr. Calum Hamilton discuss the clinical criteria that listeners should look out for, indicating a subtype of mild cognitive impairment known as DLB, which could potentially progress into a full dementia with Lewy body phenotype.

Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209499

Blood Biomarkers to Detect Alzheimer Disease - Part 1 Aug 30, 2024

Show notes

In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the diagnostic performance of blood biomarkers for Alzheimer disease in clinical cohorts.

Show reference:

https://jamanetwork.com/journals/jama/fullarticle/2821669

Blood Biomarkers to Detect Alzheimer Disease - Part 1 Aug 30, 2024

Show notes

Show reference:

https://jamanetwork.com/journals/jama/fullarticle/2821669

Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1 Aug 29, 2024

Show notes

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Calium discuss the risk of developing dementia among patients with MCI at three or five-year time points.

Show reference:

https://www.neurology.org/doi/10.1212/WNL.0000000000209499

New Treatment Option for Parkinson Disease Aug 28, 2024

Show notes

Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease.

Show reference:

https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496